REGN Stock Ownership Activity

REGENERON PHARMACEUTICALS 13F holders

2 value investing gurus have made changes to the REGENERON PHARMACEUTICALS (REGN) position according to the gurus' latest SEC quarterly report(s). REGN has been completely sold out by 1 guru(s), the number of REGN shares has been decreased by 1 super investor(s).

Which gurus or hedge funds are buying REGN now?

According to the latest SEC filing(s) REGENERON PHARMACEUTICALS (REGN) has not been purchased by any super investor.

To see more about who is investing in REGENERON PHARMACEUTICALS (REGN), please go to the REGN ownership page.

History
Name
Company
%
Activity
Share
Change
% change to
Portfolio
% of
Portfolio
2014 Q3 (2 results)
David M. Polen
Polen Capital Management
+164.59%
+343,312
+2.78%
4.47%
Ole Andreas Halvorsen
Viking Global Investors
-63.53%
-1,882,774
-2.73%
0.00%
Current price: $610.64 69.38% AVG reported price*: $360.52
2014 Q2 (2 results)
Ole Andreas Halvorsen
Viking Global Investors
+181.75%
+1,911,656
+2.36%
3.65%
David M. Polen
Polen Capital Management
-4.82%
-10,573
-0.07%
1.29%
Current price: $610.64 116.18% AVG reported price*: $282.47
2014 Q1 (2 results)
Ole Andreas Halvorsen
Viking Global Investors
buy
+1,051,800
+1.32%
1.32%
David M. Polen
Polen Capital Management
+12,416.45%
+217,412
+1.41%
1.42%
Current price: $610.64 103.36% AVG reported price*: $300.28
2013 Q2 (1 result)
David M. Polen
Polen Capital Management
buy
+1,751
+0.01%
0.01%
Current price: $610.64 171.38% Reported price*: $225.01
7 of 56

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.